Boston Partners boosted its stake in shares of MetLife, Inc. (NYSE:MET) by 2.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,056,257 shares of the financial services provider’s stock after buying an additional 45,634 shares during the quarter. Boston Partners owned approximately 0.19% of MetLife worth $106,823,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Daiwa Securities Group Inc. grew its position in MetLife by 19.5% during the third quarter. Daiwa Securities Group Inc. now owns 246,148 shares of the financial services provider’s stock valued at $12,787,000 after buying an additional 40,237 shares during the period. One Capital Management LLC grew its position in MetLife by 4.1% during the third quarter. One Capital Management LLC now owns 43,370 shares of the financial services provider’s stock valued at $2,253,000 after buying an additional 1,716 shares during the period. Klingenstein Fields & Co. LLC grew its position in MetLife by 3.1% during the third quarter. Klingenstein Fields & Co. LLC now owns 410,352 shares of the financial services provider’s stock valued at $21,318,000 after buying an additional 12,345 shares during the period. American Century Companies Inc. grew its position in MetLife by 7.3% during the third quarter. American Century Companies Inc. now owns 6,006,510 shares of the financial services provider’s stock valued at $312,038,000 after buying an additional 408,890 shares during the period. Finally, State of Wisconsin Investment Board grew its position in MetLife by 3.8% during the third quarter. State of Wisconsin Investment Board now owns 1,349,141 shares of the financial services provider’s stock valued at $70,088,000 after buying an additional 49,444 shares during the period. Institutional investors own 73.79% of the company’s stock.
Shares of MetLife, Inc. (NYSE:MET) opened at $52.20 on Friday. The firm has a market cap of $55,571.91, a P/E ratio of 10.16, a P/E/G ratio of 1.33 and a beta of 1.51. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $44.26 and a one year high of $55.91.
MetLife (NYSE:MET) last announced its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.19. The business had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. MetLife had a negative net margin of 0.75% and a positive return on equity of 8.81%. MetLife’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period last year, the firm posted $1.28 earnings per share. equities analysts anticipate that MetLife, Inc. will post 4.43 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 13th. Investors of record on Monday, November 6th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date is Friday, November 3rd. MetLife’s dividend payout ratio is currently -320.00%.
MetLife announced that its Board of Directors has authorized a share repurchase plan on Wednesday, November 1st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase shares of its stock through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
TRADEMARK VIOLATION WARNING: This piece of content was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://stocknewstimes.com/2017/11/11/boston-partners-boosts-position-in-metlife-inc-met.html.
In related news, insider Christopher G. Townsend sold 82,731 shares of the firm’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the sale, the insider now directly owns 49,660 shares of the company’s stock, valued at $2,711,436. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christopher G. Townsend sold 55,712 shares of the firm’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the sale, the insider now directly owns 25,181 shares in the company, valued at $1,367,076.49. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.
Several equities research analysts have commented on the stock. Langen Mcalenn reaffirmed a “buy” rating on shares of MetLife in a report on Wednesday, August 16th. Zacks Investment Research raised shares of MetLife from a “hold” rating to a “buy” rating and set a $60.00 price objective on the stock in a report on Thursday. ValuEngine downgraded shares of MetLife from a “strong-buy” rating to a “buy” rating in a report on Thursday. Sandler O’Neill downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Friday. Finally, B. Riley reaffirmed a “neutral” rating on shares of MetLife in a report on Monday, November 6th. One research analyst has rated the stock with a sell rating, ten have given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. MetLife presently has a consensus rating of “Buy” and a consensus price target of $58.40.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).
Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.